|
Online Database of Chemicals from Around the World | 产品搜索 | 产品提交 | 产品推广 |
网站主页 >> 化工产品目录 >> >> 市场分析报告 |
市场分析报告 |
|
vTv Therapeutics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis ... for the treatment of Alzheimer's disease (AD) is azeliragon (TTP488), an orally administered, small molecule ... Global Market Report of NA (CAS 603148-36-3) December 2024 Dementia with Diabetes – Pipeline Insight, 2020 ... Diabetes Emerging Drugs Azeliragon (TTP488): vTv Therapeutics Azeliragon (TTP488) is developed by ... in patients with type 2 diabetes. Azeliragon (TTP488) is an orally bioavailable small ... from the US FDA for Azeliragon in Alzheimer's disease. Further product ... Alzheimer's Disease [2017] ... ) CAD106 (amilomotide; Novartis) Pioglitazone (Takeda) Azeliragon (PF-04494700/TTP-488; vTv Therapeutics ... Global Alzheimer’s Drug Market: Trends, Opportunities and Forecasts (2015-2020) (By Type - Imaging, Therapeutics, Diagnostics, Biomarkers; By Age: <65 years, >65 years age; By Region; Global Dementia Market) Executive Summary Progressive numbers of neurological disorders along with escalating demand for drugs to control of Alzheimer Disease. The Global Alzheimer’s Market is growing at a moderate rate over last five years on account of rising expenditure on ... Alzheimer's disease (AD) - Pipeline Insight, 2020 ... Elenbecestat (E2609) Octohydroaminoacridine Succinate Gantenerumab Azeliragon (TTP488) ALZT-OP1 AZT-211 ... Global Alzheimer Market Report: 2015 Edition Alzheimer’s disease is defined as an advanced neurological disorder that increasingly deprives patients of their memory and ability to carry out daily activities. As it grows in a human brain, individuals are likely to practice difficulties in linguistic, ... |